Sampei, Z.; Koo, C.X.; Teo, F.J.; Toh, Y.X.; Fukuzawa, T.; Gan, S.W.; Nambu, T.; Ho, A.; Honda, K.; Igawa, T.;
et al. Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies 2023, 12, 36.
https://doi.org/10.3390/antib12020036
AMA Style
Sampei Z, Koo CX, Teo FJ, Toh YX, Fukuzawa T, Gan SW, Nambu T, Ho A, Honda K, Igawa T,
et al. Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies. 2023; 12(2):36.
https://doi.org/10.3390/antib12020036
Chicago/Turabian Style
Sampei, Zenjiro, Christine Xing’er Koo, Frannie Jiuyi Teo, Ying Xiu Toh, Taku Fukuzawa, Siok Wan Gan, Takeru Nambu, Adrian Ho, Kiyofumi Honda, Tomoyuki Igawa,
and et al. 2023. "Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement" Antibodies 12, no. 2: 36.
https://doi.org/10.3390/antib12020036
APA Style
Sampei, Z., Koo, C. X., Teo, F. J., Toh, Y. X., Fukuzawa, T., Gan, S. W., Nambu, T., Ho, A., Honda, K., Igawa, T., Ahmed, F., Wang, C.-I., Fink, K., & Nezu, J.
(2023). Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies, 12(2), 36.
https://doi.org/10.3390/antib12020036
